ICD112J ;ALB/MJF - YEARLY DRG UPDATE; October 01, 2020@15:42
 ;;18.0;DRG Grouper;**112**;October 20, 2000;Build 8
 ;
 ; Updates for DRGS 640-809
 Q
 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
 ;;640^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC^1.2653^3.4
 ;;641^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC^0.7702^2.6
 ;;642^10^MED^INBORN AND OTHER DISORDERS OF METABOLISM^1.4033^3.3
 ;;643^10^MED^ENDOCRINE DISORDERS WITH MCC^1.6437^5.1
 ;;644^10^MED^ENDOCRINE DISORDERS WITH CC^1.0191^3.5
 ;;645^10^MED^ENDOCRINE DISORDERS WITHOUT CC/MCC^0.7426^2.6
 ;;650^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITH MCC^4.6439^6.6
 ;;651^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITHOUT MCC^3.5462^5.6
 ;;652^11^SURG^KIDNEY TRANSPLANT^3.0851^4.5
 ;;653^11^SURG^MAJOR BLADDER PROCEDURES WITH MCC^5.5567^10.1
 ;;654^11^SURG^MAJOR BLADDER PROCEDURES WITH CC^2.8425^5.4
 ;;655^11^SURG^MAJOR BLADDER PROCEDURES WITHOUT CC/MCC^2.1587^3.4
 ;;656^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC^3.3053^5.3
 ;;657^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC^1.8780^2.8
 ;;658^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC^1.5790^1.8
 ;;659^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH MCC^2.5769^5.9
 ;;660^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC^1.4112^3.0
 ;;661^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC^1.0779^1.8
 ;;662^11^SURG^MINOR BLADDER PROCEDURES WITH MCC^3.0387^7.0
 ;;663^11^SURG^MINOR BLADDER PROCEDURES WITH CC^1.5250^3.5
 ;;664^11^SURG^MINOR BLADDER PROCEDURES WITHOUT CC/MCC^1.1267^1.8
 ;;665^11^SURG^PROSTATECTOMY WITH MCC^3.0603^7.4
 ;;666^11^SURG^PROSTATECTOMY WITH CC^1.7219^3.6
 ;;667^11^SURG^PROSTATECTOMY WITHOUT CC/MCC^0.9839^1.9
 ;;668^11^SURG^TRANSURETHRAL PROCEDURES WITH MCC^2.8229^7.0
 ;;669^11^SURG^TRANSURETHRAL PROCEDURES WITH CC^1.5742^3.7
 ;;670^11^SURG^TRANSURETHRAL PROCEDURES WITHOUT CC/MCC^0.9875^2.0
 ;;671^11^SURG^URETHRAL PROCEDURES WITH CC/MCC^1.8315^3.7
 ;;672^11^SURG^URETHRAL PROCEDURES WITHOUT CC/MCC^1.0417^1.6
 ;;673^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MCC^3.4940^8.0
 ;;674^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH CC^2.3705^6.0
 ;;675^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITHOUT CC/MCC^1.6864^3.0
 ;;682^11^MED^RENAL FAILURE WITH MCC^1.4866^4.3
 ;;683^11^MED^RENAL FAILURE WITH CC^0.8949^3.1
 ;;684^11^MED^RENAL FAILURE WITHOUT CC/MCC^0.6048^2.2
 ;;686^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC^1.6978^4.7
 ;;687^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH CC^1.0398^3.2
 ;;688^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC^0.8664^2.0
 ;;689^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITH MCC^1.1471^3.8
 ;;690^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC^0.7956^2.8
 ;;693^11^MED^URINARY STONES WITH MCC^1.4308^3.7
 ;;694^11^MED^URINARY STONES WITHOUT MCC^0.7971^2.0
 ;;695^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITH MCC^1.1483^3.6
 ;;696^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITHOUT MCC^0.6930^2.3
 ;;697^11^MED^URETHRAL STRICTURE^0.9924^2.6
 ;;698^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC^1.6025^4.8
 ;;699^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH CC^1.0121^3.2
 ;;700^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITHOUT CC/MCC^0.7408^2.3
 ;;707^12^SURG^MAJOR MALE PELVIC PROCEDURES WITH CC/MCC^1.9953^2.3
 ;;708^12^SURG^MAJOR MALE PELVIC PROCEDURES WITHOUT CC/MCC^1.4847^1.4
 ;;709^12^SURG^PENIS PROCEDURES WITH CC/MCC^2.4120^4.3
 ;;710^12^SURG^PENIS PROCEDURES WITHOUT CC/MCC^1.4414^1.9
 ;;711^12^SURG^TESTES PROCEDURES WITH CC/MCC^2.0434^5.1
 ;;712^12^SURG^TESTES PROCEDURES WITHOUT CC/MCC^1.2416^2.5
 ;;713^12^SURG^TRANSURETHRAL PROSTATECTOMY WITH CC/MCC^1.4819^2.6
 ;;714^12^SURG^TRANSURETHRAL PROSTATECTOMY WITHOUT CC/MCC^0.9582^1.5
 ;;715^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITH CC/MCC^2.2332^5.2
 ;;716^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITHOUT CC/MCC^1.3143^1.5
 ;;717^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITH CC/MCC^1.7703^3.4
 ;;718^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITHOUT CC/MCC^1.2690^1.9
 ;;722^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MCC^1.6977^4.9
 ;;723^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH CC^1.1524^3.3
 ;;724^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.7651^1.8
 ;;725^12^MED^BENIGN PROSTATIC HYPERTROPHY WITH MCC^1.2493^4.0
 ;;726^12^MED^BENIGN PROSTATIC HYPERTROPHY WITHOUT MCC^0.7716^2.5
 ;;727^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITH MCC^1.4368^4.6
 ;;728^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITHOUT MCC^0.8217^2.9
 ;;729^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITH CC/MCC^1.0778^3.3
 ;;730^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITHOUT CC/MCC^0.6558^2.0
 ;;734^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH CC/MCC^2.1852^3.4
 ;;735^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITHOUT CC/MCC^1.2722^1.7
 ;;736^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC^4.2652^8.0
 ;;737^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC^2.0235^4.0
 ;;738^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.4038^2.3
 ;;739^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC^3.9023^6.5
 ;;740^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC^1.8024^2.7
 ;;741^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.3129^1.6
 ;;742^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH CC/MCC^1.8021^2.8
 ;;743^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT CC/MCC^1.1706^1.6
 ;;744^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITH CC/MCC^1.8983^4.4
 ;;745^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITHOUT CC/MCC^1.1508^2.0
 ;;746^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITH CC/MCC^1.5634^3.3
 ;;747^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT CC/MCC^0.9786^1.5
 ;;748^13^SURG^FEMALE REPRODUCTIVE SYSTEM RECONSTRUCTIVE PROCEDURES^1.4172^1.5
 ;;749^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITH CC/MCC^2.5262^5.3
 ;;750^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITHOUT CC/MCC^1.4270^2.1
 ;;754^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.7369^4.8
 ;;755^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC^1.0811^3.1
 ;;756^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.9968^2.1
 ;;757^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.3722^4.7
 ;;758^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH CC^0.9555^3.5
 ;;759^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6204^2.5
 ;;760^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITH CC/MCC^0.9666^2.6
 ;;761^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITHOUT CC/MCC^0.5657^1.5
 ;;768^14^SURG^VAGINAL DELIVERY WITH O.R. PROCEDURES EXCEPT STERILIZATION AND/OR D&C^1.1468^2.8
 ;;769^14^SURG^POSTPARTUM AND POST ABORTION DIAGNOSES WITH O.R. PROCEDURES^1.6613^2.9
 ;;770^14^SURG^ABORTION WITH D&C, ASPIRATION CURETTAGE OR HYSTEROTOMY^0.8658^1.6
 ;;776^14^MED^POSTPARTUM AND POST ABORTION DIAGNOSES WITHOUT O.R. PROCEDURES^0.6971^2.2
 ;;779^14^MED^ABORTION WITHOUT D&C^1.0186^2.2
 ;;783^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH MCC^1.9297^4.7
 ;;784^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH CC^1.0440^3.1
 ;;785^14^SURG^CESAREAN SECTION WITH STERILIZATION WITHOUT CC/MCC^0.9121^2.6
 ;;786^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH MCC^1.6150^4.2
 ;;787^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH CC^1.0653^3.2
 ;;788^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITHOUT CC/MCC^0.8724^2.7
 ;;789^15^MED^NEONATES, DIED OR TRANSFERRED TO ANOTHER ACUTE CARE FACILITY^1.8258^1.8
 ;;790^15^MED^EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME, NEONATE^6.0211^17.9
 ;;791^15^MED^PREMATURITY WITH MAJOR PROBLEMS^4.1121^13.3
 ;;792^15^MED^PREMATURITY WITHOUT MAJOR PROBLEMS^2.4812^8.6
 ;;793^15^MED^FULL TERM NEONATE WITH MAJOR PROBLEMS^4.2240^4.7
 ;;794^15^MED^NEONATE WITH OTHER SIGNIFICANT PROBLEMS^1.4951^3.4
 ;;795^15^MED^NORMAL NEWBORN^0.2024^3.1
 ;;796^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH MCC^1.3130^3.6
 ;;797^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH CC^0.9279^2.1
 ;;798^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITHOUT CC/MCC^0.9279^2.1
 ;;799^16^SURG^SPLENECTOMY WITH MCC^5.2077^7.6
 ;;800^16^SURG^SPLENECTOMY WITH CC^2.6585^4.4
 ;;801^16^SURG^SPLENECTOMY WITHOUT CC/MCC^1.7960^2.6
 ;;802^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MCC^3.8120^8.2
 ;;803^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH CC^2.0533^4.1
 ;;804^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITHOUT CC/MCC^1.2618^1.8
 ;;805^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH MCC^1.0056^2.8
 ;;806^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH CC^0.6978^2.3
 ;;807^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITHOUT CC/MCC^0.6314^2.0
 ;;808^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC^2.1410^5.1
 ;;809^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC^1.2157^3.4
 ;;EXIT
